Publications
Sort:
Open Access Issue
Preparation and efficacy evaluation of anti-M blood group antibodies based on specific agglutination screening and molecular modeling
Journal of Nanjing Medical University (Natural Sciences) 2026, 46(11): 1649-1658
Published: 15 November 2026
Abstract PDF (7.7 MB) Collect
Downloads:0
Objective

To establish a strategy combining specific erythrocyte agglutination screening with molecular modeling for the efficient preparation of anti-M blood group antibodies, and to verify their clinical detection efficacy.

Methods

An agglutination screening strategy targeting intact erythrocytes was adopted, combined with flow cytometry sorting to obtain anti-M specific B cells for B cell receptor (BCR) sequencing. Evolutionary biological analysis was performed on the antibody variable region sequences, and molecular modeling was integrated to predict antigen-antibody binding affinity. Candidate sequences were screened to construct expression plasmids, and recombinant antibodies were expressed in a eukaryotic system. Erythrocyte agglutination test, titer determination and flow cytometry were used to verify antibody binding specificity, and erythrocyte samples with different MN phenotypes were employed to evaluate its blood group identification efficacy.

Results

From the blood sample with an anti-M antibody titer of 1∶512, 96 anti-M specific B cells were obtained via specific agglutination screening, and 28 pairs of heavy and light chain variable region sequences were acquired through BCR sequencing. Six candidate antibodies were screened for expression and verification based on evolutionary biological analysis and molecular modeling, among which 2G9, 2F11, and 2H5 could specifically agglutinate M antigen-positive erythrocytes, with 2G9 showing the highest agglutination titer (1∶256). Flow cytometry confirmed that2G9 could specifically recognize the M antigen, and this antibody achieved a 100% detection rate and 0% false positive rate for M blood group in erythrocytes with different MN phenotypes.

Conclusion

The anti-M blood group antibody 2G9 prepared in this study has excellent clinical testing efficacy and can be used for clinical M blood group identification. The specific agglutination screening of red blood cells combined with molecular modeling strategies provides a new method for the preparation of blood group antibodies.

Total 1